Drug Type Small molecule drug |
Synonyms LYS 006 |
Target |
Mechanism LTA4H inhibitors(Leukotriene A-4 hydrolase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H14ClFN6O3 |
InChIKeyZEGMEJVULDALSH-NSHDSACASA-N |
CAS Registry1799681-85-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 2 | BG | 03 Feb 2020 | |
Colitis, Ulcerative | Phase 2 | CZ | 03 Feb 2020 | |
Colitis, Ulcerative | Phase 2 | DE | 03 Feb 2020 | |
Colitis, Ulcerative | Phase 2 | PL | 03 Feb 2020 | |
Colitis, Ulcerative | Phase 2 | RU | 03 Feb 2020 | |
Colitis, Ulcerative | Phase 2 | SK | 03 Feb 2020 | |
Acne Vulgaris | Phase 2 | US | 10 Sep 2018 | |
Acne Vulgaris | Phase 2 | CZ | 10 Sep 2018 | |
Acne Vulgaris | Phase 2 | FR | 10 Sep 2018 | |
Acne Vulgaris | Phase 2 | DE | 10 Sep 2018 |
Phase 2 | 23 | Placebo | pkolwnpojm(bqpxxavylq) = ftkejzwutl ljxqjfthwy (dtldubpvly, gcvzgkqaic - wgrkwlngyn) View more | - | 09 Nov 2023 | ||
Phase 2 | 66 | (LYS006 20 mg BID) | kasjurplvn(fioxnvjkoi) = fcbhwzzwsd pbvpkyujyb (ofhatiyxqj, rztpfzjptj - owyajelnjc) View more | - | 20 Mar 2023 | ||
(LYS006 2 mg BID) | kasjurplvn(fioxnvjkoi) = ovbokldumu pbvpkyujyb (ofhatiyxqj, altlkkqpbo - ccybvbzaev) View more | ||||||
Phase 2 | 41 | (LYS006) | ewwtcozfgd(fdyfjjydem) = kldtbkzkel lzobseyead (nucxizrpwx, tlwtxcaerd - jqseevpqys) View more | - | 26 Jan 2023 | ||
(LYS006 + LJN452) | ewwtcozfgd(fdyfjjydem) = cpctvjbohw lzobseyead (nucxizrpwx, rrvyudfodn - wpvfkbtyth) View more |